![[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc](https://www.europesays.com/ch/wp-content/uploads/2026/07/1785239847_https2F2Fmedia.zenfs_.com2Fen2Fglobenewswire.com2F84b0110bbf60eb8397db0461bc3549c4-380x220.jpeg)
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc
Key figures CHF millions % change January–June 2026 2025 At CER1 In CHF In USD Group sales 30,364…
![[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc](https://www.europesays.com/ch/wp-content/uploads/2026/06/1781246635_d295bae68c32358ba6ac888e76c1cca2.png)
